Women spend 25% more of their lives in poor health than men, and closing that gap could add at least $1 trillion a year to the global economy by 2040, according to the McKinsey Health Institute. Yet the same research finds FemTech companies received just 3% of total digital-health funding. That mismatch between need and capital is exactly where founders and investors find opportunity, and Qatar now has a structured route into it: the QSTP × Merck FemTech Accelerator, whose 30-startup cohort has its final showcase scheduled for November.

The size of the gap

The McKinsey Health Institute report, published in January 2024, sets out why women's health is a market and not a niche:

  • Time in poor health: women spend 25% more time in poor health than men, which the report puts at around nine years for the average woman.
  • Economic value: closing the gap could boost the global economy by at least $1 trillion annually by 2040.
  • Underinvestment: FemTech companies received 3% of total digital-health funding, and the report notes that only 4% of US healthcare-related R&D efforts target women's health.

For founders, the takeaway is that the problem is large, the evidence base is thin, and capital has not yet caught up. For investors, under-allocation of this kind is often where returns come from, though, as with any sector thesis, that is a judgment rather than a guarantee.

How the QSTP × Merck FemTech Accelerator works

According to QSTP's programme page, the accelerator brings together 30 FemTech startups in a multi-phase, hybrid format with pilot opportunities across Qatar and the WANA region. Key terms:

  • No equity and no cost. QSTP states that it does not take any equity as part of the programme.
  • Market access: introductions to healthcare providers, regulators and industry partners.
  • Pilots: the FAQ lists patient access, data access, wet labs and dry labs.
  • Mentorship and visibility: QSTP's mentor and investor network, Merck's expertise, and regional showcases.

The programme targets deep-tech startups, including AI, robotics and material science, addressing women's health across areas such as cardiovascular and autoimmune conditions, mental health, chronic disease in women, diagnostics, digital health and fertility. Applicants were expected to show a scalable model, traction such as revenue, pilots, partnerships or users, and readiness to operate in WANA. Startups could apply from anywhere in the world.

The published timeline ran from a global online intake in April–May, through a Doha immersion in June and pilot execution from July to November, with a regional expansion stop in Egypt in September–October. The final showcase and roadshow, presenting pilot outcomes to leaders and investors, is scheduled for November in Doha. Applications for this cohort closed on 25 March.

Where the openings are

Reading the McKinsey evidence alongside the accelerator's focus list suggests several areas where Qatar-based founders could build. This is general guidance rather than a ranking:

  • Chronic disease in women, where conditions often present or progress differently and evidence specific to women is limited.
  • Diagnostics, including tools that shorten the time to diagnosis for conditions that are frequently missed.
  • Maternal health, where pilots can be designed around clearly defined patient pathways.
  • Mental health and life-stage care, such as menopause, which digital models can reach at scale.
  • Research participation, the infrastructure that ensures women are represented in the studies that shape care.

A worked example: TrialHer

TrialHer, a member of the current cohort, shows how a startup can use the programme to approach Qatar's health system. As profiled by QSTP on 10 November 2026, the Geneva-headquartered company, founded by CEO Hyatt Antognini-Amin, works to involve women in shaping medical research, not only enrolling them once a study is designed.

The company's own survey of more than 500 women found that over 70% had never been invited to take part in health research, and 91% said they would help co-design research if their time were fairly valued. These are TrialHer's figures, not an independent study.

Through the accelerator, TrialHer is exploring a regional base in Doha. QSTP describes a proposed pilot with Weill Cornell Medicine-Qatar, still under exploration, that would involve up to 100 women and focus on gestational diabetes and the factors that influence women's participation in research. The lesson for other founders is the shape of the approach: a defined condition, a credible clinical partner, a small and measurable cohort, and a clear research question. Its founder's advice is practical: "Involve women while there is still room for their input to change what you're building."

The Qatar Vision 2030 connection

The human development pillar of Qatar National Vision 2030 centres on learning and healthcare, and the economic pillar aims for a varied, competitive economy. FemTech sits where the two meet: it can improve health outcomes for women in Qatar while building a knowledge-based industry that exports to the wider region. Programmes that offer patient access, data access and lab facilities to startups help turn that alignment into real companies. For the wider health context, see After QMED 2026: Where Healthtech Startups Fit in Qatar's National Health Strategy.

What to do next

  • Founders: pick one condition and one patient pathway, and design a pilot with a small, measurable cohort and a credible clinical partner before seeking scale.
  • Founders: involve women users in product and study design early, and separate your own survey data from independent evidence when you pitch.
  • Investors: watch the November showcase for pilot outcomes. Data from structured pilots is a stronger signal than pitch-deck projections.
  • Everyone: monitor QSTP's channels for the next accelerator intake, and review the Hub's map of support for women founders in Qatar for adjacent programmes.

Sources

  • Closing the women's health gap: A $1 trillion opportunity to improve lives and economies (January 2024) – McKinsey Health Institute – mckinsey.com
  • QSTP × Merck FemTech Accelerator – Qatar Science & Technology Park – qstp.qa
  • Women Deserve More Than a Place in Clinical Trials: Meet TrialHer (10 November 2026) – Qatar Science & Technology Park – qstp.qa
  • Qatar National Vision 2030 – Government Communications Office – gco.gov.qa

Photo: Tima Miroshnichenko / Pexels

Latest Stories

This section doesn’t currently include any content. Add content to this section using the sidebar.